SAN DIEGO, April 14, 2016 (GLOBE NEWSWIRE) -- The passing of Harper Howard left a void in the hearts of many around the world as the condition that she bravely fought, CDKL5, ultimately took her life in January.  What her parents, Penny and Dustin Howard, could not have imagined was the extent of the legacy that their beloved daughter, Harper, left by donating her body tissue to science.

Not only did Harper gift the world’s first 28-month daily cannabidiol CBD hemp oil brain to be “banked” for medical research, she also donated a massive deep tissue sample. With only three and a half months since her passing, Harper’s contribution to science is already having a profound impact on medical research for a wide range of neurological conditions under the guidance of UCSD School of Medicine’s lead stem cell researcher, Dr. Alysson Muotri.

On what would have been Harper’s 6th birthday, April 12th, the Howards arranged a visit to Dr. Muotri to see their daughter’s living legacy first-hand. Labeled “HH,” Harper’s tissue cells are now growing into new live brain cells that can be directly compared to her “banked” brain cells on the East Coast. 

Conditions that Dr. Muotri is researching include: CDKL5, epilepsy, autism, Rett’s Syndrome and many other neurological conditions. These new brain cells will be tested for cannabidiol (CBD) – a component of cannabis (marijuana and hemp) – as well as other drugs. The impact that Harper’s donation will have on medical research is just beginning to be realized.

The intent of the visit was to help bring closure to the family.

“This is a big deal and I’m the one who wanted it the most, I think, to come to see her on her birthday,” Penny Howard told FOX 5 News. “This is huge for us as a family.  And then to find out actually how significant the donation was to science made it even more special.”

After becoming visibly seizure-free, Harper began living a life of a typical child with an older sister and younger brother. With assistance, she learned to ride a horse, swim, enjoyed dressing up and having her fingernails painted – as long as she picked the color. She went on to shatter the image of a child with “special needs” and was crowned the reigning National American Miss Princess Cover Girl for the state of Texas.

And Harper didn’t stop there.  As chronicled in an article published by the Huffington Post, Harper’s progress posted on’s Facebook blog was the catalyst for the historic decision by Brazil’s government to import Medical Marijuana, Inc.’s Real Scientific Hemp Oil™ (RSHO™) – and subsidize payments for RSHO™ under the Brazilian government’s health care system.

With her final gift to medical research, Harper has effectively added having a direct impact on global neurological and cannabis research to her glowing list of accomplishments – all before the age of six. 

It is clear that while one chapter in Harper’s life has come to a close, her spirit lives on. To learn more about Harper Howard’s living legacy, visit

About HempMeds®
HempMeds® offers mainstream marketing, sales, customer service, and logistics for the cannabis industry. HempMeds® is a corporate portfolio company of Medical Marijuana, Inc. (OTC Pink:MJNA) and the Company’s exclusive master distributor and contracted marketing company. In addition to handling sales and distribution, HempMeds® is the communication hub for the Medical Marijuana Inc. portfolio of companies.

About Medical Marijuana Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry and develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit

The Company is committed to consistently providing the highest-quality CBD hemp oil products on the market. To see Medical Marijuana, Inc.’s video statement, click here. Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.

Medical Marijuana Inc. and HempMeds do not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.

For further information, please contact:

Public Relations contact:
Andrew Hard
CMW Media
P. 888-829-0070

Corporate contact:
Medical Marijuana, Inc.
Toll Free: 888-OTC-MJNA (888-682-6562)

Investor Relations:
Nicholas R. Massalas
Director of Business Development
Medical Marijuana Inc.
OTC Symbol: MJNA 

Toll Free: (877) 964.6463
Direct: (858) 264-6505